Novavax scores narrower Covid vaccine approval
Digest more
Top News
Overview
Impacts
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.